Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Jenkinson

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
European Journal of Pharmacology|May 19, 1993
Dequalinium: a potent inhibitor of apamin-sensitive K+ channels in hepatocytes and of nicotinic responses in skeletal muscleN A Castle, D G Haylett, J M Morgan, et al.
Bioorganic & Medicinal Chemistry|June 15, 2007
Synthesis and pharmacological testing of polyaminoquinolines as blockers of the apamin-sensitive Ca2+-activated K+ channel (SK(Ca))David I Fletcher, C Robin Ganellin, Alessandro Piergentili, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|July 31, 2010
Failure of intimate partner violence screening among patients with substance use disordersEsther K Choo, Christina Nicolaidis, Robert H Jenkinson, et al.
Journal of Medicinal Chemistry|September 23, 2000
bis-Quinolinium cyclophanes: 8,14-diaza-1,7(1, 4)-diquinolinacyclotetradecaphane (UCL 1848), a highly potent and selective, nonpeptidic blocker of the apamin-sensitive Ca(2+)-activated K(+) channelJ Q Chen, D Galanakis, C R Ganellin, et al.
The Journal of Physiology|September 5, 2001
SK3 is an important component of K(+) channels mediating the afterhyperpolarization in cultured rat SCG neuronesR Hosseini, D C Benton, P M Dunn, et al.
Journal of Medicinal Chemistry|January 23, 1998
Bis-quinolinium cyclophanes: 6,10-diaza-3(1,3),8(1,4)-dibenzena-1,5(1,4)- diquinolinacyclodecaphane (UCL 1684), the first nanomolar, non-peptidic blocker of the apamin-sensitive Ca(2+)-activated K+ channelJ C Rosa, D Galanakis, C R Ganellin, et al.
British Journal of Pharmacology|March 2, 1999
Differences in the actions of some blockers of the calcium-activated potassium permeability in mammalian red cellsD C Benton, C J Roxburgh, C R Ganellin, et al.
British Journal of Pharmacology|January 1, 1996
Discrimination between subtypes of apamin-sensitive Ca(2+)-activated K+ channels by gallamine and a novel bis-quaternary quinolinium cyclophane, UCL 1530P M Dunn, D C Benton, J Campos Rosa, et al.
The Journal of Hospital Infection|February 10, 2009
Healthcare-associated infection in acute hospitals: which interventions are effective?A Mears, A White, B Cookson, et al.
Pharmacological Reviews|June 1, 1995
International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. IX. Recommendations on terms and symbols in quantitative pharmacologyD H Jenkinson, E A Barnard, D Hoyer, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
European Journal of Pharmacology|May 19, 1993
Dequalinium: a potent inhibitor of apamin-sensitive K+ channels in hepatocytes and of nicotinic responses in skeletal muscleN A Castle, D G Haylett, J M Morgan, et al.
Bioorganic & Medicinal Chemistry|June 15, 2007
Synthesis and pharmacological testing of polyaminoquinolines as blockers of the apamin-sensitive Ca2+-activated K+ channel (SK(Ca))David I Fletcher, C Robin Ganellin, Alessandro Piergentili, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|July 31, 2010
Failure of intimate partner violence screening among patients with substance use disordersEsther K Choo, Christina Nicolaidis, Robert H Jenkinson, et al.
Journal of Medicinal Chemistry|September 23, 2000
bis-Quinolinium cyclophanes: 8,14-diaza-1,7(1, 4)-diquinolinacyclotetradecaphane (UCL 1848), a highly potent and selective, nonpeptidic blocker of the apamin-sensitive Ca(2+)-activated K(+) channelJ Q Chen, D Galanakis, C R Ganellin, et al.
The Journal of Physiology|September 5, 2001
SK3 is an important component of K(+) channels mediating the afterhyperpolarization in cultured rat SCG neuronesR Hosseini, D C Benton, P M Dunn, et al.
Journal of Medicinal Chemistry|January 23, 1998
Bis-quinolinium cyclophanes: 6,10-diaza-3(1,3),8(1,4)-dibenzena-1,5(1,4)- diquinolinacyclodecaphane (UCL 1684), the first nanomolar, non-peptidic blocker of the apamin-sensitive Ca(2+)-activated K+ channelJ C Rosa, D Galanakis, C R Ganellin, et al.
British Journal of Pharmacology|March 2, 1999
Differences in the actions of some blockers of the calcium-activated potassium permeability in mammalian red cellsD C Benton, C J Roxburgh, C R Ganellin, et al.
British Journal of Pharmacology|January 1, 1996
Discrimination between subtypes of apamin-sensitive Ca(2+)-activated K+ channels by gallamine and a novel bis-quaternary quinolinium cyclophane, UCL 1530P M Dunn, D C Benton, J Campos Rosa, et al.
The Journal of Hospital Infection|February 10, 2009
Healthcare-associated infection in acute hospitals: which interventions are effective?A Mears, A White, B Cookson, et al.
Pharmacological Reviews|June 1, 1995
International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. IX. Recommendations on terms and symbols in quantitative pharmacologyD H Jenkinson, E A Barnard, D Hoyer, et al.
Pageof 7